Apogee Therapeutics, Inc. <APGE.O>: BTIG cuts to neutral from buy
APGE•Related News
Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
XLO•
Matador Resources Chairman, CEO Joseph Foran reports $197,102 common share acquisition
MTDR•
AMCON Distributing to list on NYSE Texas Exchange on Aug. 13, 2026, maintaining NYSE American primary listing
DIT•
Altimmune Q2 FY26 net loss narrows to $22.8 million; cash and investments climb to $519 million
ALT•
Perma-Fix wins Hanford tank waste grouting, disposal IDIQ subcontract with $4.37 billion ceiling
PESI•